Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Factors Predicting ACcurately End-of-Life in Dementia With Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study

NCT04829656 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT04829656
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04829656 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Factors Predicting ACcurately End-of-Life in Dementia With Lewy Bodies and Promoting Quality End-of-Life Experiences: the PACE-DLB Study
Lead sponsor
University of Florida
Phase
Observational
Overall status
Completed
Start date
February 25, 2021
Completion date
December 31, 2025
Enrollment
378 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies